IPD 0.00% 5.8¢ impedimed limited

Ann: Market Update - Executing Towards Profitability in Oncology, page-118

  1. 805 Posts.
    lightbulb Created with Sketch. 341
    and after that little tid bit of info ..

    the BOD said the renal observational study data review was to be completed in Q3 and discussions with principal investigators re next steps ..

    have we heard anything from the BOD re any of this ..??

    crickets .. wink.png
 
watchlist Created with Sketch. Add IPD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.